QI
AGTC

QS Investors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

QS Investors’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-300
Closed -$1K – 1995
2017
Q4 		$1K Hold
300
– – ﹤0.01% 1931
2017
Q3 		$1K Hold
300
– – ﹤0.01% 1910
2017
Q2 		$2K Hold
300
– – ﹤0.01% 1691
2017
Q1 		$2K Hold
300
– – ﹤0.01% 1717
2016
Q4 		$3K Hold
300
– – ﹤0.01% 1494
2016
Q3 		$3K Hold
300
– – ﹤0.01% 1477
2016
Q2 		$4K Hold
300
– – ﹤0.01% 1490
2016
Q1 		$4K Hold
300
– – ﹤0.01% 1481
2015
Q4 		$6K Buy
+300
New +$4.63K ﹤0.01% 1460

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return

QS Investors's AGTC Position: Q1 2018 in Review

QS Investors sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2018, closing a stake of 300 shares — an estimated $1K sold.

QS Investors first reported a position in AGTC in Q4 2015 and held it in 9 quarters. The position peaked at $6K in Q4 2015. 54 funds tracked by Wall St. Rank hold AGTC as of Q1 2018.

  • QS Investors reported no remaining Applied Genetic Technologies Corporation position as of Q1 2018 after selling out during the quarter.
  • QS Investors sold 300 Applied Genetic Technologies Corporation shares in Q1 2018, an estimated $1K.
  • QS Investors first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 9 quarters.
  • QS Investors's Applied Genetic Technologies Corporation position peaked at $6K in Q4 2015.
  • 54 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2018.

Based on QS Investors's 13F filing for Q1 2018, filed 15 May 2018.